LOPERAMIDE HYDROCHL

The Defense Logistics Agency awarded a delivery order under the indefinite-delivery/indefinite-quantity contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0), a small business certified as both a small disadvantaged business and a women-owned business, for the supply of 2 packages of LOPERAMIDE HYDROCHLORIDE (NSN 6505015495732) at a total contract value of $1.60. The order, issued under solicitation SPE2DP26F7537 and dated July 14, 2026, requires delivery by July 29, 2026, to a military destination in Watertown, NY, under FOB Destination terms, meaning the contractor assumes all transportation risk and costs until receipt at the delivery point. The item must be shipped via traceable means with parcel post explicitly prohibited, and all packages must be clearly marked with the base contract number, delivery order number, and a traceable shipping identifier W51JNR61540004, while adhering to DoD logistics standards implied through the use of CAGE codes, NSNs, and destination labeling. Inspection and acceptance occur at the delivery site by an authorized government representative, with no tolerance permitted for quantity variance. Payment will be processed through the Defense Finance and Accounting Service using the provided payment code SL4701 and accounting data 97X4930 5CBX 001 2620 S33189, with the contracting officer Lisa Quinn overseeing administration and Shairy M. Cartagena serving as local medical supply chain support. The order is fully executed with no options, modifications, or additional line items and relies on the terms of the underlying IDIQ contract, with no explicit FAR clauses, MIL-STD references, or formal evaluation factors documented in the award notice, indicating a streamlined commercial fulfillment under established logistical protocols.